International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

In-Silico Structure Determination of Protein Falstatin from Malaria Parasite Plasmodium Falciparum

Author Affiliations

  • 1 Department of Biotechnology, Central University of Rajasthan, Kishangarh, INDIA

Res. J. Recent Sci., Volume 1, Issue (4), Pages 68-71, April,2 (2012)

Abstract

Malaria is the major cause of socio-economic loss to most of the developing countries. Several drugs have been developed against the deadly malaria causing protozoan, Plasmodium falciparum. However, development of drug resistance against existing drugs has necessitated the identification of new drug targets. Several proteases have been identified from malaria parasite which is involved in various processes like haemoglobin degradation, egress of merozoite etc. But more important aspect of malaria biology is the regulation of these proteases for effective regulation of parasite life cycle. Falstatin is such a protein which binds to many cysteine proteases and regulates their activities. Therefore, Falstatin is the potential target for drug discovery. In this study, we determined the three-dimensional structure of Falstatin by molecular modelling using Swiss Modeller and Sali’s Modeller. Ramachandran plot was used for structure validation. Falstatin active site was determined using CastP. Structural analysis of Plasmodium Falciparum Falstatin (Pf-Falstatin) could be instrumental in identifying new drug like molecules.

References

  1. Wu Y., Wang X., Liu X. and Wang Y., Data-mining approaches reveal hidden families of proteases in the genome of malaria parasite, Genome Res., 13, 601–616 (2003)
  2. Shenai B.R., Sijwali P.S., Singh A. And Rosenthal P.J., Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum, J Biol Chem., 275, 29000–29010 (2000)
  3. Rosenthal P.J., Cysteine proteases of malaria parasites, Int J Parasitol., 34, 1489–1499 (2004)
  4. Klemba M., Gluzman I. and Goldberg D.E., A Plasmodium falciparum dipeptidyl minopeptidase 1 participates in vacuolar hemoglobin degradation, J Biol Chem., 279, 43000–43007 (2004)
  5. Sijwali P.S. and Rosenthal P.J., Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum, Proc Natl Acad Sci U S A., 101, 4384–4389 (2004)
  6. Hadley T., Aikawa M. and Miller L.H., Plasmodium knowlesi: Studies on invasion of rhesus erythrocytes by merozoites in the presence of protease inhibitors, Exp Parasitol., 55, 306–311 (1983)
  7. Braun-Breton C., Blisnick T., Jouin H., Barale J.C., Rabilloud T., et al., Plasmodium chabaudi p68 serine protease activity required for merozoite entry into mouse erythrocytes, Proc Natl Acad Sci U S A., 89, 9647–9651 (1992)
  8. Hanspal M., Dua M., Takakuwa Y., Chishti A.H. and Mizuno A., Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development, Blood, 100, 1048–1054 (2002)
  9. Aly A.S.I. and Matuschewski K., A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts, J Exp Med, 202, 225–230 (2005)
  10. Monteiro A.C.S., Abrahamson M., Lima A., Marcos A., Santos V., et al., Indentification, characterization, and localization of chagasin, a tightbinding cysteine protease inhibitor in T. Cruzi, J Cell Sci., 114, 3933–3942 (2001)
  11. Santos C.C., Sant’Anna C., Terres A., Cunha-e Silva N.L., Scharfstein J., et al., Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells, J Cell Sci., 118, 901–915 (2005)
  12. Otto H.H. and Schirmeister T., Cysteine proteases and their inhibitors, Chem Rev, 97, 133–171 (1997)
  13. Wickham M.E., Culvenor J.G. and Cowman A.F., Selective inhibition of a two-step egress of malaria parasite from the host erythrocyte, J Biol Chem., 278, 37658–37663 (2003)
  14. Rosenthal P.J., Protease inhibitors. In: Rosenthal PJ, editor. Antimalarial chemotherapy: Mechanisms of action, resistance, and new direction in drug discovery, Humana Press., 325–345 (2001)
  15. Pandey K.C., Singh N., Arastu-Kapur S., Bogyo M. and Rosenthal P.J., Falstatin, a cysteine protease inhibitor of Plasmodium falciparum, facilitates erythrocyte invasion, PLoS Pathog, 2(11), 117 (2006)
  16. Renom M.A., Stuart A., Fiser A., Sánchez R., Melo F. and Sali A., Comparative protein structure modeling of genes and genomes, Annu Rev Biophys Biomol Struct., 29, 291-325 (2000)
  17. Lovell S.C., Davis I.W., Arendall W.B. , de Bakker P.I., Word J.M., Prisant M.G., Richardson J.S. and Richardson D.C., Structure validation by Calpha geometry: phi,psi and Cbeta deviation, Proteins., 15;50(3), 437-50 (2000)
  18. Dundas J., et. Al., CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues, Nucleic Acids Res., 34,116–118 (2006)
  19. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C. and Ferrin TE, UCSF Chimera - A Visualization System for Exploratory Research and Analysis, J Comput Chem., 25,1605-1612 (2004)